Skip to main content

Table 5 Direct cost (test and treatment cost) and comprehensive cost (including estimate of life value) of the presumptive versus the test based strategy at the current "real life" adherence levels to both strategies: test and treatment cost subsidized (see text)

From: Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso

Variables

Children, dry season

Children, rainy season

Adults, dry season

Adults, rainy season

Direct cost, presumptive strategy

264

257

608

608

Direct cost, test-based strategy

256

255

609

610

Comprehensive cost, presumptive strategy

979

596

1330

1164

Comprehensive cost, test-based strategy

1157

760

1279

1125

Threshold life value*

23

7

14

25

  1. Costs expressed in € (euro) for 1000 patients managed with either strategy, assuming a life value of 525 € (better option in bold)
  2. * Life value at which the two strategies become equivalent at sensitivity analysis